Virus-specific RNA and Antibody from Convalescent-phase SARS Patients Discharged from Hospital
Hoe Nam Leong*†1 , Kwai Peng Chan†1, Ali S Khan‡§, Lynette Oon†, Su Yun Se-Thoe†, Xin Lai Bai†, Daniel Yeo*, Yee Sin Leo*, Brenda Ang*, Thomas G. Ksiazek‡, and Ai Ee Ling†
Author affiliations: *Tan Tock Seng Hospital, Singapore; †Singapore General Hospital, Singapore; ‡Centers for Diseases Control and Prevention, Atlanta, Georgia, USA; §Global Outbreak Alert and Response Network, Geneva, Switzerland
Figure 3. Cumulative results of first serologic testing of samples by week of illness. Serologic testing was performed by indirect enzyme immunoassay with severe acute respiratory syndrome–associated coronavirus lysate as the antigen
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.